-- Ongoing Phase 1 Study Expanded to Assess Safety and Anti-Tumor Activity of ALKS 4230 With Pembrolizumab in Patients With Advanced Solid Tumors --
PR Newswire
DUBLIN, Sept. 10, 2018
PR Newswire
DUBLIN, Sept. 10, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey